The research of profile of specific autoantibodies at the different forms of EBV-infection

Authors

DOI:

https://doi.org/10.15587/2519-4798.2016.76557

Keywords:

Epstein barr viral infection, adults, immunity, autoimmune markers, antibodies to native DNA, antibodies to microsomes of liver and kidneys, dynamics

Abstract

There were presented the data of dynamics of specific autoimmune markers levels at acute and chronic forms of Epstein barr viral infection in adults. The received results testify to activation of autoimmune processes, especially in patients with chronic clinical course of disease.

Aim of research. To assess the dynamics of specific autoimmune markers in adult patients with the different variants of EB viral infection.

Methods. The study of levels of specific antibodies to phospholipids (IgM and IgG), antibodies to the native DNA IgG (ADNA 2) and antibodies IgG to microsomes of liver and kidneys (anti-LKM-1) by IEA in the dynamics of disease included 2 groups of patients (n=84), among them 44 men (52,4 %) and 40 women (47,6 %). The group of patients with acute form of EB viral infection included 48 patients (57,1 %), with chronic form – 36 patients (42,9 %). Antibodies concentration in blood serum was determined by the solid-phase immune-enzyme analysis in the dynamics of disease: at admission of patients (I period) and in the period of recovery (14-18-th day of disease) – I period on the background of etiotropic, pathogenetic and symptomatic therapy. Statistical procession of the results was carried out using the program Statistika 6.0 for Windows (Stat Soft Inc, USA).

Results. During the research it was established the increase of content of specific autoimmune parameters comparing with ones of the control group. At both acute and chronic forms the reliable increase of content of antibodies to ADNA 2 (7,96±1,4 IU/ml) and (8,98±1,1 IU/ml) was revealed comparing with parameters of the control group (5,4±1,4 IU/ml), (p<0,05). Analogous tendency was observed as to the levels of phospholipid antibodies: (4,62±1,5 IU/ml) and (4,95±1,1 IU/ml) comparing with parameters of the control group (3,6±1,8 IU/ml) and antibodies to macrosomes of liver and kidneys (anti-LKM-1) (8,64±1,5 IU/ml) and (9,36±1,11IU/ml), comparing with parameters of the control group (6,6±1,1 IU/ml), (p<0,05). At the repeated examination in II period the tendency to decrease of the studied parameters levels was observed comparing with I one, but in patients with chronic EB viral infection the level of antiphospholipid antibodies reliably exceeded the parameters of the control group of patients (4,95±1,12 IU/ml) comparing with (3,6±1,8 IU/ml), (p<0,05).

Conclusions. In patients with the different forms of EB viral infection the increase of content of specific antibodies to phospholipids (IgM and IgG), antibodies to the native DNA IgG (ADNA 2) and antibodies IgG to microsomes of liver and kidneys (anti-LKM-1)was observed and it was mostly expressed at the chronic clinical course of disease

Author Biography

Татьяна Ивановна Лядова, V. N. Karazin Kharkov national university Svobody squ., 4, Kharkiv, Ukraine, 61022

Candidate of Medical Sciences, associate professor

Department of General and Clinical Immunology and Allergology

References

  1. Nіkol'skij, І. S., Yurchenko, V. D., Nіkol'skij, K. І. (2003). Asocіjovanij aktivnoyu hronіchnoyu Epshtejna-Barr іnfekcіеyu klіnіko-іmunologіchnij sindrom. Suchasnі іnfekcіі, 3, 60–62.
  2. Straus, S. E. (1993). Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management. Annals of Internal Medicine, 118 (1), 45. doi: 10.7326/0003-4819-118-1-199301010-00009
  3. Vozіanova, Z. І., Glej, A. І. (2004). Іnfekcіjnij mononukleoz yak polіetіologіchne zahvoryuvannya. Suchasnі іnfekcіі, 2, 37–41.
  4. Isakov, V. A., Arhipova, E. I., Isakov, D. V. (2006). Gerpesvirusnye infekcii cheloveka: rukovodstvo dlya vrachej. Sankr-Peterburg, 303.
  5. Prohorova, N. A., Volchkova, E. V., Mihajlovskaya, G. V. (2008). Klinicheskoe znachenie molekulyarno-geneticheskih i serologicheskih issledovanij v diagnostike infekcionnogo mononukleoza. Infekcionnye bolezni, 6 (2), 17–20.
  6. Mavrutenkov, V. V., Nezdvec'kij, V. S., Shostakovich-Korec'ka, L. R., Kirichenko, S. V., Mavrutenkova, T. V. (2001). Autoіmunnі reakcіі pri іnfekcіjnomu mononukleozі. Perinatologіya і pedіatrіya, 3, 102.
  7. Grotto, I., Mimouni, D., Huerta, M., Mimouni, M., Cohen, D., Robin, G. et. al. (2003). Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults. Epidemiology and Infection, 131 (1), 683–689. doi: 10.1017/s0950268803008550
  8. Tugizov, S., Herrera, R., Veluppillai, P., Greenspan, J., Greenspan, D., Palefsky, J. M. (2007). Epstein-Barr Virus (EBV)-Infected Monocytes Facilitate Dissemination of EBV within the Oral Mucosal Epithelium. Journal of Virology, 81 (11), 5484–5496. doi: 10.1128/jvi.00171-07
  9. Kudin, A. P. (2006). Eta «bezobidnaya» virus Epshtejna – Barr infekciya. Chast' 1. Harakteristika vozbuditelya. Reakciya immunnoj sistemy na virus. Medicinskie novosti, 7, 25–32.
  10. Guerreiro, M., Na, I.-K., Letsch, A., Haase, D., Bauer, S., Meisel, C. et. al. (2010). Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets. European Journal of Immunology, 40 (6), 1566–1576. doi: 10.1002/eji.200940000
  11. Pender, M. P. (2009). Preventing and curing multiple sclerosis by controlling Epstein–Barr virus infection. Autoimmunity Reviews, 8 (7), 563–568. doi: 10.1016/j.autrev.2009.01.017
  12. Siennicka, J., Trzcinska, A. (2007). Laboratory diagnosis of Epstein-Barr virus infection. Med. Dosw. Mikrobiol., 59 (3), 259–266.
  13. Walther, L. E. (2005). Infectious mononucleosis. HNO, 53 (4), 383–392. doi: 10.1007/s00106-004-1210-1
  14. Vozianova, Zh. I. (2001). Infekcijni ta parazytarni hvoroby. Vol. 1. Kyiv: Zdorov’ja, 171–188.
  15. Sospedra, M., Martin, R. (2005). Immunology of multiple sclerosis. Annual Review of Immunology, 23 (1), 683–747. doi: 10.1146/annurev.immunol.23.021704.115707
  16. Lucas, R. M., Hughes, A. M., Lay, M.-L. J., Ponsonby, A.-L., Dwyer, D. E., Taylor, B. V., Pender, M. P. (2011). Epstein-Barr virus and multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 82 (10), 1142–1148. doi: 10.1136/jnnp-2011-300174
  17. Owens, G. P., Bennett, J. L. (2012). Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis. Multiple Sclerosis Journal, 18 (9), 1204–1208. doi: 10.1177/1352458512448109
  18. Draborg, A. H., Duus, K., Houen, G. (2012). Epstein-Barr Virus and Systemic Lupus Erythematosus. Clinical and Developmental Immunology, 2012, 1–10. doi: 10.1155/2012/370516
  19. James, J. A., Robertson, J. M. (2012). Lupus and Epstein-Barr. Current Opinion in Rheumatology, 24 (4), 383–388. doi: 10.1097/bor.0b013e3283535801
  20. Cadwell, K., Patel, K. K., Maloney, N. S., Liu, T.-C., Ng, A. C. Y., Storer, C. E. et. al. (2010). Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell, 141 (7), 1135–1145. doi: 10.1016/j.cell.2010.05.009
  21. Peacock, J. W., Elsawa, S. F., Petty, C. C., Hickey, W. F., Bost, K. L. (2003). Exacerbation of experimental autoimmune encephalomyelitis in rodents infected with murine gammaherpesvirus-68. European Journal of Immunology, 33 (7), 1849–1858. doi: 10.1002/eji.200323148

Downloads

Published

2016-08-31

How to Cite

Лядова, Т. И. (2016). The research of profile of specific autoantibodies at the different forms of EBV-infection. ScienceRise: Medical Science, (8 (4), 36–41. https://doi.org/10.15587/2519-4798.2016.76557

Issue

No. 8 (4) (2016)

Section

Medical Science

License

Copyright (c) 2016 Татьяна Ивановна Лядова

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.